Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129206) titled 'A Real-World Study on the Safety and Efficacy of Transcranial Time-Interference Stimulation (TI) in Patients with Multiple System Atrophy (Cerebellar Type)' on Aug. 1.

Study Type: Observational study

Study Design: Single arm

Primary Sponsor: The Second Qilu Hospital of Shandong University

Condition: Multiple system atrophy (cerebellar type)

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-08-05

Target Sample Size: Transcranial temporal interference stimulation (TI) therapy group:40;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.htm...